Dr. Reddy's Laboratories (RDY) Tmuɣli n wazal
Rdy
Ṛṛbem n lḥedd$12.26Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-0.24%
Asnulfu n AI: RDY
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Dr. Reddy’s Laboratories Ltd. provides a full range of pharmaceutical services. The company manufactures bulk drugs and formulations, including verapamil and cephalexin. It also produces and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The company sells its products in India and worldwide.
